Young-Whan Kim

The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2010, Lung cancer.

Expression of Class III Beta-Tubulin Correlates with Unfavorable Survival Outcome in Patients with Resected Non-small Cell Lung Cancer

C. Kang, Y. Bang, Dong-Wan Kim, 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study.

Hojoong Kim, H. Yum, I. Oh, 2009, Lung cancer.

Clinicopathologic Characteristics and Outcomes of Patients with Anaplastic Lymphoma Kinase-Positive Advanced Pulmonary Adenocarcinoma: Suggestion for an Effective Screening Strategy for These Tumors

Y. Bang, Dong-Wan Kim, D. Heo, 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Differential sensitivities to tyrosine kinase inhibitors in NSCLC harboring EGFR mutation and ALK translocation.

Y. Bang, Dong-Wan Kim, D. Heo, 2012, Lung cancer.

Patterns of palliative procedures and clinical outcomes in patients with advanced non-small cell lung cancer.

C. Lee, Dong-Wan Kim, D. Heo, 2009, Lung cancer.

The relationship between response to previous systemic treatment and the efficacy of subsequent pemetrexed therapy in advanced non-small cell lung cancer.

Y. Bang, Dong-Wan Kim, D. Heo, 2010, Lung cancer.